Publications

Journal Article Systematic Review Epublish

PubMed: 40453586 DOI: 10.3389/fendo.2025.1541744

Review of Mendelian randomization studies on common male-specific diseases.

Front Endocrinol (Lausanne) 16:1541744

Authors: Qixin Pang, Zhe Chang, Hao Liu, Jianshe Chen, Sicheng Ma, Chenming Zhang, Zixue Sun

Affiliations

  • Traditional Chinese Medicine (ZHONG JING) School, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.
  • School of Foreign Languages, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.
  • Queen Mary College, Nanchang University, Nanchang, Jiangxi, China.
  • Reproductive Medicine Department, Henan Province Hospital of Traditional Chinese Medicine, Zhengzhou, Henan, China.
  • The Second Clinical Medical School, Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.

Abstract

Although numerous Mendelian randomization studies on risk factors have been conducted in male medicine, a systematic synthesis of these findings is still lacking. This review searched relevant literature in PubMed and the Web of Science published before May 2024; systematically summarized the progress in the application of Mendelian randomization in male infertility, erectile dysfunction, prostate cancer, and prostatitis; summarized and classified the risk factors affecting men's health, such as the gut microbiota, modifiable risk factors and related diseases; and presented some problems and solutions that were presented in these studies. This information offers valuable insights into the etiology and pathogenesis of male-specific diseases.

MeSH

Erectile Dysfunction, Prostatitis, Prostatic Neoplasms, Risk Factors, Infertility, Male, Random Allocation